title: Neurogenic airway microvascular leakage induced by toluene inhalation in rats.
abstract: Toluene is a representative airborne occupational and domestic pollutant that causes eye and respiratory tract irritation. We investigated whether a single inhalation of toluene elicits microvascular leakage in the rat airway. We also evaluated the effects of CP-99,994, a tachykinin NK(1) receptor antagonist, and ketotifen, a histamine H1 receptor antagonist with mast cell-stabilizing properties, on the airway response. The content of Evans blue dye that extravasated into the tissues was measured as an index of plasma leakage. Toluene (18-450 ppm, 10 min) concentration-dependently induced dye leakage into the trachea and main bronchi of anesthetized and mechanically ventilated rats. Toluene at concentrations of ≥ 50 and ≥ 30 ppm caused significant responses in the trachea and main bronchi, respectively, which both peaked after exposure to 135 ppm toluene for 10 min. This response was abolished by CP-99,994 (5 mg/kg i.v.), but not by ketotifen (1mg/kg i.v.). Nebulized phosphoramidon (1 mM, 1 min), a neutral endopeptidase 24.11 inhibitor, significantly enhanced the response induced by toluene (135 ppm, 10 min) compared with nebulized 0.9% saline (1 min). These results show that toluene can rapidly increase airway plasma leakage that is predominantly mediated by tachykinins endogenously released from airway sensory nerves. However, mast cell activation might not be important in this airway response.
authors.affiliation: Department of Hygiene, Yamaguchi University Graduate School of Medicine, Kogushi 1-1-1, Ube 755-8505, Japan. sakamoto@yamaguchi-u.ac.jp
authors.forename: Tatsuo
authors.initials: T
authors.lastname: Sakamoto
authors.forename: Michihiro
authors.initials: M
authors.lastname: Kamijima
authors.forename: Mio
authors.initials: M
authors.lastname: Miyake
mesh_terms: D000818:Animals; D001980:Bronchi / Q000098:blood supply / Q000187:drug effects / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D006020:Glycopeptides / Q000494:pharmacology; D019570:Inhalation Exposure; D007665:Ketotifen / Q000494:pharmacology; D008297:Male; D008407:Mast Cells / Q000187:drug effects / Q000378:metabolism; D055806:Microvessels / Q000187:drug effects* / Q000473:pathology; D020078:Neurogenic Inflammation / Q000139:chemically induced* / Q000473:pathology; D010880:Piperidines / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D012997:Solvents / Q000008:administration & dosage / Q000633:toxicity*; D015320:Tachykinins / Q000378:metabolism; D013997:Time Factors; D014050:Toluene / Q000008:administration & dosage / Q000633:toxicity*; D014132:Trachea / Q000098:blood supply / Q000187:drug effects / Q000473:pathology
chemical_list: D006020:Glycopeptides; D010880:Piperidines; D012997:Solvents; D015320:Tachykinins; C080755:3-(2-methoxybenzylamino)-2-phenylpiperidine; D014050:Toluene; C008890:phosphoramidon; D007665:Ketotifen